Imbiba’s investment in boutique gym firm 1Rebel will see site numbers increase

Staff
By Staff

Imbiba has given a cash injection to fund the expansion of boutique gym chain 1Rebel after closing a new £90million fund

Imbiba, a leisure and hospitality investor, has injected funds into the boutique gym chain 1Rebel to fuel its expansion, following the closure of a new £90million fund.

This investment will drive the establishment of additional gym locations for the brand which currently operates 13 venues. Darrel Connell, managing partner at Imbiba, said 1Rebel, is the “best in class” in the UK and recognising its potential for further growth.

The announcement comes as Imbiba, known for supporting brands like Pizza Pilgrims, Farmer J, and F1 Arcade, verifies the closing of their oversubscribed second investment fund worth £90 million. This fund will be channelled towards high-growth ventures in the leisure, lifestyle, wellness, and entertainment industries.

Mr Connell attested to 1Rebel meeting Imbiba’s conditions of being a “proven” business set on scaling and launching new sites. He said: “We see the macro-economic headwinds that are widely written about, but actually there are lots of really good businesses out there that are doing really well, working really hard, and 1 Rebel is a classic example.

“It is absolutely thriving now. People prioritise certain things as their discretionary spend comes down and people in that environment prioritise paying for a 1Rebel class.”

Presently, the company runs 10 fitness centres in London and three in Australia and the Middle East. James Balfour, the co-founder and chief executive of 1Rebel, said: “Securing this investment from Imbiba marks a pivotal moment for our business.

“We are thrilled to have their support and confidence as we continue our mission to redefine fitness and wellness. With this new infusion of capital, we’re poised to accelerate our growth, expand our reach, and further enhance the 1Rebel experience for our members.”

Share This Article
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *